The Brown-RIH-RITM collaboration has been a productive scientific relationship for over 25 years. In the past 15 years, these two institutions have cooperated on the administration and execution of 4 NIH grants with substantial activities shared between the two institutions. These grants have included: 1 TMRC, 2 RO- 1s, a K23 and 1 on-going UO1 RCT. These projects have resulted in a strong administrative link between Brown, CIHR RIH and RITM that will ensure the smooth administration ofthe many sub-contracts included in this TMRC application. The Core A will be responsible to Projects 1,2,3, Core B &C for the following: 1) establish administrative and financial communication that will coordinate activities for Project 1, including the production of a GMP grade recombinant Sj97 vaccine at the CIHR RIH laboratory, 2) organize and support travel for investigators to meet and plan the TMRC projects, 3) organize and support meetings, workshops and training of laboratory and field workers, 4) organize the hiring of laboratory, field staff and data entry clerks, 5) organize and support the extensive travel within the Philippines between the Palo field lab and RITM, 6) procure, negotiate (via solicitation of bids where appropriate), purchase (including purchase of carabaos), install, and maintain (via service contracts where appropriate) relevant equipment and supplies for the execution ofthe project aims, 7) organize and support meetings with stakeholders (PCC, CHD EV,RTR hospital and RHU) and support the attendance of project staff at all relevant TMRC related and mandated meetings, 8) co-ordinate the collection, packaging (in accordance with lATA requirements), shipping and tracking of appropriate samples from the Palo field lab to RITM, 9) organize and support travel for Core B technologist to travel to the CIHR lab at RIH for training in the development and production of multi-plexed assay kits and technology.

Public Health Relevance

Core A will have the general oversight and leadership ofthe entire TMRC program. This oversight will involve strategic planning, financial review, coordination of Project and Core functions and interactions, and routine administrative functions.

National Institute of Health (NIH)
National Institute of Allergy and Infectious Diseases (NIAID)
Specialized Center (P50)
Project #
Application #
Study Section
Special Emphasis Panel (ZAI1)
Project Start
Project End
Budget Start
Budget End
Support Year
Fiscal Year
Total Cost
Indirect Cost
Research Institute for Tropical Medicine
Muntinlupa City
Zip Code
Botelho, Monica C; Alves, Helena; Richter, Joachim (2017) Halting Schistosoma haematobium - associated bladder cancer. Int J Cancer Manag 10:
Botelho, M C; Alves, H; Richter, J (2017) Estrogen catechols detection as biomarkers in schistosomiasis induced cancer and infertility. Lett Drug Des Discov 14:135-138
Jiz, Mario A; Wu, Haiwei; Olveda, Remigio et al. (2015) Development of Paramyosin as a Vaccine Candidate for Schistosomiasis. Front Immunol 6:347
Olveda, David U; Olveda, Remigio M; Lam, Alfred K et al. (2014) Utility of Diagnostic Imaging in the Diagnosis and Management of Schistosomiasis. Clin Microbiol 3:
Inobaya, Marianette T; Olveda, Remigio M; Chau, Thao Np et al. (2014) Prevention and control of schistosomiasis: a current perspective. Res Rep Trop Med 2014:65-75
Olveda, David U; Li, Yuesheng; Olveda, Remigio M et al. (2013) Bilharzia: Pathology, Diagnosis, Management and Control. Trop Med Surg 1:
Ross, Allen G P; Olveda, Remigio M; Acosta, Luz et al. (2013) Road to the elimination of schistosomiasis from Asia: the journey is far from over. Microbes Infect 15:858-65